Achieving person-centred care

Professor Gregory Mattingly discusses the value of person-centred care in the treatment of schizophrenia and how it can be initiated in practice.

The views and opinions expressed in this video do not necessarily reflect those of Lundbeck and Otsuka.

Page: AU-ABIM-0583. September 2024. Video: AU-REXU-0387. November 2023.

  • Box
    Body

    REXULTI PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia

  • text
    Body

    Please review Approved Product Information before prescribing.
    Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:

    REXULTI PI

    REXULTI® is a registered trademark of H. Lundbeck A/S. REXULTI® is co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.

Related

Related